Quotes from the news wire:
The first trial in the programme is planned for initiation in first quarter of 2016 and will investigate the efficacy and safety of once-daily oral semaglutide doses of 3 mg, 7 mg and 14 mg, compared to once-daily oral anti-diabetic sitagliptin dose of 100 mg, the remaining six trials of the PIONEER programme are all expected to be initiated during 2016.
Share your thoughts on Novo Nordisk's quotes with the community:
Would you like us to send you a FREE inspiring quote delivered to your inbox daily?
Use the citation below to add this author page to your bibliography:
"Novo Nordisk Quotes." Quotes.net. STANDS4 LLC, 2020. Web. 29 Oct. 2020. <https://www.quotes.net/authors/Novo+Nordisk+Quotes>.